[Stats] number needed to treat, or i am not interested
I have had 15 orders now and I keep a table, so here is the honest summary rather than a vibe.
Material has been consistent. Communication has not. Shipping has varied by about 20 days on nominally the same lane, which matters more in summer than in February.
The independent number came back 98.4% against a claimed 98.6%, which I read as agreement rather than a discrepancy — inter-lab variance on this assay is a point or two either way and treating one lab as ground truth is how people end up in pointless arguments with vendors.
Batch number is in the comments. Ask if you want the method.
best — the order this archive was captured in
What was the dropout rate?
absolute risk reduction, not relative risk reduction, that is how you decide
give the trial name, phase, n, and primary endpoint in the body
Phase 2 TRIUMPH looked amazing. Phase 3 trials are harder. Do not anchor on phase 2 readouts.
the discontinuation arms are the interesting part, not the STEP endpoints
off-label use data is different from approved-indication data
off-label use data is different from approved-indication data
Flair changed to match the content. Read the sidebar before posting next time and we are square.
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
phase 2 is not phase 3, smaller n and shorter trial
- 1What was the dropout rate?4 comments in this branch · started by u/slow_logbook_notes30
- 2off-label use data is different from approved-indication data4 comments in this branch · started by u/sofia_wikstrom